Nalaganje...
Managing Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors Through Co-Targeting MEK/ERK Signaling
Although epidermal growth factor receptor (EGFR)-targeted therapy has improved clinical outcomes of patients with advanced non-small-cell lung cancer (NSCLC) carrying activating EGFR mutations, the development of acquired resistance to EGFR tyrosine kinase inhibitors (EGFR-TKIs), including the promi...
Shranjeno v:
| izdano v: | Lung Cancer (Auckl) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7872905/ https://ncbi.nlm.nih.gov/pubmed/33574724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S293902 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|